针对人类表皮生长因子受体2阳性的向治疗的进展在晚期胃癌中是积极的
Ya-Kun Jiang1, Wei Li2, Ying-Yang Qiu3
1Department of Gastroenterology, Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, Shandong Province, China.
World journal of gastrointestinal oncology
|July 12, 2024
概括
向治疗,包括单克隆抗体和小分子抑制剂,为HER2阳性胃癌提供了新的选择. 这些先进的治疗方法旨在克服耐药性并改善结果,特别是对于那些没有对传统疗法做出反应的患者.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 向治疗,特别是对HER2阳性胃癌的向治疗,补充了传统的化学放射治疗.
- 人类表皮生长因子受体2 (HER2) 是胃癌治疗的关键标.
- 特拉斯图祖马布加化疗是高级胃癌的标准一线治疗方法.
研究的目的:
- 在胃癌中审查各种超越传统单克隆抗体的HER2向疗法的疗效.
- 探索替代HER2向策略,以克服当前治疗方法的局限性.
- 讨论小分子抑制剂和抗体药物合物的胃癌治疗中的潜力.
主要方法:
- 对胃癌的HER2向疗法现有文献的综述.
- 分析不同治疗类的机制,优势和局限性.
- 对单克隆抗体,小分子氨酸激酶抑制剂和抗体-药物结合物的临床证据的讨论.
主要成果:
- 单克隆抗体,如珀图祖马布和马格图克西马布,显示出经过验证的安全性和有效性.
- 小分子氨酸激酶抑制剂 (例如,拉帕提尼布,皮洛提尼布) 提供了诸如血脑屏障穿透和口服生物可用性等优势.
- 抗体-药物联体 (例如,T-DM1,T-DXd) 可以克服对单克隆抗体的抗性.
结论:
- 针对HER2的疗法对于胃癌治疗至关重要,目前正在开发新型药物.
- 小分子抑制剂和抗体-药物联合体代表了单克隆抗体的有希望的替代品和补充剂.
- 基于详细的患者分层的个性化治疗策略将增强各种 HER2 向药物的胃癌作用.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:26Peptic Ulcer Disease IV: Management
85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K